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Abstract
Ameloblastoma is the most common odontogenic tumor of epithelial origin, and though it is of a benign nature, 
it frequently infiltrates the bone, has a high rate of recurrence and could potentially become malignant. Cellular 
adhesion potentially plays an important role in the manifestation of these characteristics and in the tumor biology 
of ameloblastomas. Losses of cell-cell and extracellular matrix adhesion and cohesion are among the first events 
that occur in the invasion and growth of tumors of epithelial origin. The present review includes a description of 
the molecules that are involved in cell adhesion as reported for various types of ameloblastomas and discusses the 
possible roles of these molecules in the biological behaviors of this odontogenic tumor. Knowledge of the complex 
mechanisms in which these molecules play a role is critical for the research and discovery of future therapeutic 
targets.
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Introduction
Cell adhesion molecules (CAMs) are found at the sur-
faces of all cells, where they allow dynamic processes 
to take place during tissue morphogenesis and dur-
ing the development and maintenance of adult tissues. 
These molecules are essential to the maintenance of 
stratified epithelial structures because they participate 
in the processes of cell renewal and mobility and are 
fundamental to cell junctions and extracellular matrix 
(ECM) interactions (1). More than 50 CAMs have been 
identified; and form large superfamilies. Most proteins 
connect the extracellular and intracellular environ-
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ments, as they are comprised of structures that bind 
junctions between the cytoskeleton and the ECM or 
between cells. Through these structures, the cell ex-
ecutes signaling and signal transduction functions and 
regulates processes such as cell division, migration and 
differentiation. These structures also have important 
functions during the development of dental organs. Al-
though the function of CAMs in dental development is 
not currently well understood, it is known that CAMs 
participate in cell-cell and ECM-cell interactions dur-
ing histomorphogenesis in the different stages of odon-
togenesis (2,3). Cell adhesion interactions are strictly 
regulated, which involves numerous cell signaling path-
ways that are responsible for regulating the expression 
of cell adhesion molecules and the duration of adhesive 
contacts. This control ensures the integrity and stabil-
ity of morphogenesis and tissue maintenance. However, 
many of these processes are dysregulated in various tu-
mors, which permits tumor progression, recurrence, in-
vasion and metastasis. The loss of cell adhesion allows 
neoplastic cells to escape their places of origin, degrade 
the ECM, acquire motility, invade tissues and possibly 
cause metastasis (2,4). Ameloblastomas (AMs) are lo-
cally infiltrative benign tumors that rarely convert to 
malignancy, though they are locally invasive and carry 
a high risk of recurrence (3,4). 
The World Health Organization (WHO) has classified 
this neoplasia into the following variants: solid/multi-
cystic ameloblastoma (SMA), unicystic ameloblastoma 
(UA), desmoplastic ameloblastoma (DA) and peripheral 
ameloblastoma (PA), as well as malignant counterparts 
such as malignant ameloblastoma (MA) and ameloblas-
tic carcinoma (AC) (5). A tumoral invasion of neoplastic 
cells into surrounding healthy tissues is a characteristic 
that promotes progression and recurrence. Therefore, 
the infiltrative property of AMs is a characteristic that 
is potentially associated with alterations in tumor cell 
CAMs (6). The molecular mechanisms of tumor inva-
sion have not been clearly defined; consequently, our 
study focuses on a review of CAMs to better understand 
the relationships that exist between these molecules and 
AM tumor cell invasion (Table 1).
Cell Adhesion Molecules
-Cadherins
Cadherins are CAMs that are expressed on cell mem-
branes in the adherens junction and that have the abil-
ity to communicate with different intracellular controls 
(7). Cadherins are classified as follows: E (epithelial), P 
(placenta), M (muscle), N (nerve), B (brain) and R (ret-
ina) cadherins, and these molecules can combine with 
α-, β- and γ-catenin (7). Cytoplasmic controls connect 
actin filaments to the cell cytoskeleton and, in this way, 
can regulate the adhesive capacities of cadherins (8). 
Studies of the functions of cadherins in AMs have been 
motivated by the presence of E, P, and N cadherins in 
the enamel and because of the roles that cadherins play 
in odontogenesis (9,10). One such study was conducted 
by Alvez-Pereira et al. (10), in which immunohisto-
chemistry was used to discover the strong expression 
of E-cadherin on cells that were similar to the stellate 
reticulum of AMs. This result suggested that high con-
centrations of this molecule exist in specific sites of the 
stellate reticulum, which promote adhesion in distant 
cells. Furthermore, various authors have studied the 
E-cadherin promoter hypermethylation as an impor-
tant factor in the malignant transformations of various 
carcinomas (11). From these references, it is apparent 
that previous studies have attempted to associate E-
cadherin promoter hypermethylation with malignant 
transformations in AMs. However, such studies have 
concluded that E-cadherin promoter hypermethylation 
in AMs might not be associated with tumor progres-
sion (12,13). As mentioned previously, E-cadherin is an 
important regulator of cell adhesion; therefore, the loss 
of E-cadherin could be associated with tumor advance-
ment in AMs. The maintenance of E-cadherin expres-
sion in well-differentiated tumors can be interpreted as 
the conservation of adhesion between tumor cells and 
the tissue architecture, which is associated with a bet-
ter patient prognosis. However, in poorly differentiated 
tumors, E-cadherin expression was diminished, which 
suggests a loss of adhesions between the tumor-forming 
cells (Fig. 1). This result could indicate that the malig-
nant neoplasms are capable of spreading by invasion 
and metastasis, which correlates with a poor patient 
prognosis (14).
-β-Catenin
β-Catenin is a protein that participates in cell-cell ad-
hesions and is important for the regulation of adhesion 
complexes. Along with cadherin subunits, this 92-kDa 
protein forms a protein complex that participates in the 
adherent junctions that are necessary for cell adhesion 
and growth regulation. β-catenin plays an important 
role in the Wnt canonical pathway, and after its inter-
action with Wnt,  acquires the ability to control fun-
damental mechanisms of cell proliferation, cell polarity 
and cell fate determination during embryonic develop-
ment and adult tissue homeostasis (15). The dysregula-
tion of β-catenin is related to the genesis of numerous 
malignant neoplasias, indicating an important role for 
this molecule in tumor progression (16).  Various im-
munohistochemistry analyses of β-catenin in AMs have 
indicated that β-catenin is expressed in the cytoplasm 
and cell membrane, as well as in columnar epithelial 
cells that resemble the stellate reticulum. However, 
nuclear expression of β-catenin was observed mainly 
in the SMA variants and in odontogenic carcinomas 
(10,16,17). This finding is important because the nu-
clear expression or nuclear accumulation of β-catenin 
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Molecules Cell-cell ECM-
cell
Participation in 
odontogenesis 
PCa CCb Stroma Expression relate to 
biological behavior 
Ref. 
E-cadherin Yes No Modulator during 
development tooth, 
participate in 
morphodifferentation of the 
odontogenic epithelium of 
ameloblastos. Promotes the 
adhesion between distant 
cells. 
Positive Positive Negative Absence or decrease is 
relationated to invasive 
behavior 
10,19 
?-catenin Yes No Participates in cell-cell 
adhesion and in Wnt 
signaling pathway during 
odontogenesis, especially 
at the bell stage.  
Positive Positive Negative Nuclear expression may be 
associated with tumorigenesis 
and cell proliferation. 
10,16,
17 
?-catenin Yes No This protein is associated 
with E-cadherin to form 
linkage to cytoeskeleton 
and is an important 
modulator during tooth 
development, retaining 
cytodifferentiation of 
odontogenic epithelium. 
Positive Positive Negative The expression is significantly 
correlated with E-cadherin and 
the reduction maybe 
associated with invasive 
behavior. 
19 
SDC-1 Yes Yes Plays an important role in 
the maintenance of 
proliferation and movement 
in dental follicle cells, 
participates in formation of  
junctional epithelium. 
Positive Positive The stromal 
expression is 
possibly associated 
with  decreased 
expression in 
epithelial tumor 
cells. 
The reduction possibly has a 
role in the invasion and 
infiltration of tumor islands in 
the surrounding stroma. 
Additionally, when the SDC-1 
expression is reduced, the 
proliferative activity of the cells 
is increased. 
21,29 
CD56 Possible Possible Maybe have an important 
role morphoregulatory 
during tooth molar 
development. 
Positive Positive Weak The high expression maybe is 
relationated to development 
AM. 
30-32 
CD147 Possible Possible This protein participates in 
perivascular cells, may 
promote the capability to 
differentiation in 
odontoblast. 
Positive Positive Moderately in loose 
connective tissue. 
Increased expression in 
fibroblast possibly reflects 
continuous growth potential of 
the tumor as it degrades 
extracellular matrix by 
collagenase activity. 
31 
?-integrin Yes Yes Integrins constitute an 
important component in 
organization and tension of 
the cytoeskeleton and that 
in turn strongly influence in 
intracellular phenomena 
that possibly are implicated 
in growth, adeshion, 
migration, proliferation, 
apoptosis and cellular 
morphology. 
  Positive  35-37 
?2    Positive Positive  Decreased expression maybe 
related to growth and invasion 
and conjunction with ?1 (?2?1) 
is related with recurrence and 
tumor progression. 
35-37 
?3    Positive Positive  In conjunction with ?1 (?3?1), 
the focal expression in basal 
membrane contributes to the 
infiltrative behavior. 
35-37 
?5    Positive Positive  In conjunction with ?1 (?5?1) a 
decreased expression, 
increased incidence of 
metastases. 
35-37 
??    Positive Positive  An abundant presence may be 
related to proliferation and 
invasion. 
35-37 
?-integrin Yes Yes See ?-integrin   Positive  35-37 
?1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive Positive  A decreased expression may 
be related with growth and 
invasion. 
 
35-37 
Claudins 
 
Yes No Maybe particpate in 
activation of various MMPs 
leading to controlled enamel 
matrix formation. 
Positive Positive Negative A decreased expression is 
related to tumoral progression. 
38,39 
Table 1. Expression of different cell adhesion molecules and their participation in: odontogenesis, tumorigenesis and biological be-
havior of AM. 
a= Peripheral cell of AM, b= Central cell of AM.
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might indicate abnormal Wnt signaling, which could be 
related to tumorigenesis and cell proliferation in AMs 
(16-18) (Fig. 1).
Therefore, the nuclear accumulation of β-catenin might 
be related to AM variants that exhibit aggressive, inva-
sive and recurrent behaviors and might also be associ-
ated with increased cell proliferation (13,16,17).
-α-Catenin
α-Catenin is a protein that associates with E-cadherin; 
together, these proteins form links with the cytoskel-
eton proteins and allow for the maintenance of epithelial 
tissues, thus playing an important role in organogenesis 
and morphogenesis. As such, the loss of α-catenin ex-
pression might be associated with dedifferentiation, in-
vasion and metastasis (17). The expression patterns of 
E-cadherin and α-catenin in AMs are similar to those 
in the enamel organ that maintains odontogenic epithe-
lium cytodifferentiation (19). Kumamoto and Ooya (19) 
have conducted a study of E-cadherin and α-catenin, 
concluding that the expression of these two molecules 
could be indicative of conserved cell-cell adhesion. Ad-
ditionally, E-cadherin and α-catenin expression are uni-
formly distributed within the cell-cell boundary, which 
indicates conservation of cell adhesion functions. Stud-
ies have associated the expression of these two proteins 
with dedifferentiation, invasion and metastatic potential 
(18,19). In malignant neoplasias, an important reduction 
in the expression of both proteins was observed, which 
agreed with studies that demonstrated evidence of MA 
intraosseous invasion and lymphatic metastasis and 
reported a prominent reduction in the expression of E-
cadherin and α-catenin (19) (Fig. 1). 
-Syndecans
Syndecans form the largest family of heparin sulfate 
proteoglycans, which are expressed on the surfaces 
of all adherent cells, as well as on many non-adherent 
cells. In mammals, syndecans consist of a family of 
four members, and each is coded from a different gene 
(20). The most important and most well studied of 
these members is Syndecan-1 (SDC-1), which is main-
ly expressed on epithelial and plasma cells (20). SDC-1 
participates in cell-cell and ECM-cell adhesions and is 
considered an important structural maintenance pro-
tein, along with other molecules such as collagens I, 
II, III, IV; fibronectin; thrombospondin; and tenascin. 
SDC-1 co-participates with growth factors such as ba-
sic fibroblast growth factor (bFGF), vascular endothe-
lial growth factor VEGF and epidermal growth factor 
(EGF), among others (21-23). SDC-1 is mainly located 
on the basolateral surfaces of simple epithelial and sur-
rounding stratified epithelial cells. Although SDC-1 
is not present on the majority of mesenchymal cells 
Fig. 1. Schematic representation of the roles of CAMs in cell-cell and cell-ECM junctions in an AM neoplastic cell. Loss of E-cadherin and 
α-catenin are indicative of invasion and possibly metastasis. A dysregulation of β-catenin affects the Wnt canonical pathway, this alteration 
maybe is associated with accumulation of β-catenin in cytoplasm, this accumulation causes translocation of β-catenin to the nucleus, activates 
the transcription factors (TCF/LEF) that promote cell proliferation and tumorigenesis. The loss of SDC-1 in epithelial cells is associated with 
tumor progression and accumulation of SDC-1 in the stroma, this accumulation possibly is associated to activation of growth factors heparin 
binding, these factors possibly are involved in the invasion and tumoral progression. A dysregulation of integrins are relationated to growth and 
tumor invasion. Possibly a dysregulation of CD56 and CD147 are related to growth and tumor invasion. 
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in mature tissues, its expression is observed in small 
quantities within mesenchymatous cells in culture 
(23,24). SDC-1 gene expression, ranging from over-
expression to complete absence, has been studied in 
various types of carcinomas (25-29). In squamous cell 
carcinomas, the loss of this protein is commonly as-
sociated with greater levels of invasion and metastasis. 
In the particular case of AMs, differential expression 
of SDC-1 has been observed in diverse histological 
types, which suggests that this protein participates in 
the biological behavior of these tumors, (Fig. 2). Vari-
Fig. 2. a) Epithelial expression of SDC-1 in normal oral mucosa, this expression is observed in surrounding of epithelial cells, and is indicative 
that cells have an adequate cell-cell adhesion. b) Epithelial expression of SDC-1 in acanthomatous variant of SMA, this expression is associated 
with the maintenance of epithelial morphology, anchorage-dependent growth and inhibition of invasiveness.   
ous studies have suggested that SDC-1 gene expression 
in AMs is related to the AM variant or histological 
type (28,29). Immunohistochemistry techniques have 
revealed increased SDC-1 gene expression in the UA, 
DA and PA variants and reduced expression in SMA, 
recurrent SMA and AC. Therefore, it has been sug-
gested that the loss of SDC-1 gene expression is related 
to tumor progression and that stromal gene expression 
of SDC-1 might be associated with the activation of 
various growth factors that are related to invasion, 
progression and metastasis. In this way, SDC-1 plays 
an important role in carcinogenesis and the interos-
seous invasion of AMs. Studies conducted by Otaibi 
et al. (21) demonstrated increased stromal SDC-1 gene 
expression in the SMA and AM variants, with body 
extensions to the mandibular nerve branches, and in 
variants that crossed the cell midline. Therefore, it is 
possible that the stromal expression of SDC-1 is in-
dicative of more aggressive and recurrent AM variants 
(Fig. 1).
-N-CAM (CD56) and neurothelin (CD147)
Various surface antigens are involved in the aggrega-
tion, organization and metastatic nature of tumor cells. 
CD56 is a transmembrane protein that belongs to the 
immunoglobulin superfamily and is a specific marker 
for natural killer (NK) cells. CD56 plays an important 
morphoregulatory role through an interaction between 
the epithelium and mesenchymal cells that are derived 
from neural crest cells. It is possible that this molecule is 
essential to the formation of the basic structures of teeth 
and periodontal tissue (30,31). CD147, a transmembrane 
protein that belongs to the immunoglobulin superfami-
ly, has been described as a soluble factor that acts in cell 
adhesion and collagenase activity stimulation in fibrob-
lasts (31,32). CD56 and CD147 are similar molecules that 
might contribute to cell-cell and ECM-cell adhesions 
and can participate in the aggregation and migration of 
tumor cells (31). In AMs, CD56 expression is observed 
in the peripheral cells at tumor sites and is absent in 
the stellate reticulum, whereas CD147 is expressed with 
greater intensity in the peripheral cells of tumor sites. 
Cairns et al. (32) observed that the expression of CD147 
was limited to the cell membranes of columnar amel-
oblast-like cells and to the periphery of epithelial cell 
nests and SMA epithelial chords. From these molecular 
characteristics, it can be hypothesized that CD147 and 
CD56 expression in AM epithelial cells might indicate 
an ability to degrade the ECM and to promote continu-
ous tumor growth and invasion (31) (Fig. 1).
-Integrins
Various types of cells cannot proliferate without being 
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anchored to ECM substrates. Therefore, ECM proteins 
play an important role in the interactions between the 
epithelium and mesenchyme. Such proteins are impor-
tant components of the cytoskeletal organization and 
tension and thus can strongly influence intracellular 
phenomena, such as proliferation and cell differentiation 
(33). Integrins constitute an important family of trans-
membrane receptor proteins  that bind to cell surfaces 
and to ECM ligands, where they participate in anchor-
ing to the ECM proteins and in the modulation of mul-
tiple molecules that are involved in growth, adhesion, 
migration, proliferation, apoptosis and cell morphology 
(34,35). The above data indicate that integrins can ac-
tivate multiple molecules necessary for cell survival. 
Therefore, the dysregulation of these molecules might 
be related to tumor invasion (34). Modolo et al. (35) ob-
served strong expression of the α1, α2, α3, α5, αv, β1, β3 
and β4 integrins in follicular, acanthomatous and plexi-
form SMAs, as well as in luminal UAs. The authors also 
found that the α3, α5, αv, β1 and β4 integrins were ex-
pressed in the acanthomatous areas of acanthomatous 
SMAs, whereas in luminal UAs, the integrins were pre-
dominantly expressed in the basal strata.  Moreover, in 
follicular SMAs, the integrin expression was observed 
at the peripheral layers of neoplastic follicle basal cells, 
which suggests that the integrins interacted strongly in 
the basal membranes. These data suggest that decreases 
in integrin expression are related to tumor growth and 
the invasion of neighboring structures (35), which is 
supported by the lack of integrin expression in meta-
static tumors. Nevertheless, α2 integrin expression lev-
els are low in AMs in comparison to those in the den-
tal laminates and dental germ, which might be related 
to the characteristics of growth and invasion in AMs. 
These data suggest that in AMs, such effects are caused 
by the modified repertoire of integrins of neoplastic 
cells, which regulate anti-adhesive and adhesive events 
in tumor development and thereby explain the observed 
differences in expression levels (35-37)  (Fig. 1).
-Claudins
Claudins are a family of proteins that participate in tight 
junctions, they are present in epithelial and endothelial 
cells and are important to functions of barrier, electric 
resistance and paracellular ionic selectivity, also par-
ticipates significantly in embryogenesis and organogen-
esis, mainly in the epithelial-mesenchymal transition 
(38). Due to their characteristics, claudins have been 
studied in various tumors and their absence or overex-
pression are related to behavior. Bello et al. (38) found 
in AM an intense immunoreactivity of claudins 1, 4 y 7, 
principally in stellate reticulum like cells, this increased 
expression can indicate the effort of these proteins to 
maintain cell-cell adhesion in where commonly ex-
ist formation of microcysts and is considerate that ex-
pression of claudins 1, 4 y 7 maybe are related to cystic 
degeneration. Claudin 1 intense expression is seen in 
regions of squamous differentiation in AM, this find-
ing is important because claudin 1 is distributed in all 
squamous epithelia cells and has an important partici-
pation in cell junctions, whereby this expression maybe 
associated with squamous diferentiation of AM (39). In 
the AC, the expression of claudins 1, 4 y 7 is generally 
weak or moderate and it can be correlated to aggressive 
behavior of these carcinomas, remembering the absence 
or decrease of expression of claudin 7 is related with 
invasion or bad prognosis of carcinomas (38,39). 
Consequently changes in the expression of these pro-
teins maybe related to events of tumoral development 
of AM.
Conclusions
Diverse types of molecules and gene alterations af-
fect the development and progression of odontogenic 
tumors, and these characteristics appear to depend 
on diverse molecular mechanisms. In AMs, epithelial 
odontogenic neoplastic cells are influenced by a series 
of molecular alterations that promote tumor growth and 
tissue invasion. Of these alterations, the loss or dysregu-
lation of various CAMs is critical to the process, as cell 
adhesion is fundamental to the biological behaviors of 
odontogenic tumors. The mechanism that could explain 
the influence of such molecular alterations in tumor ad-
vancement and progression is not yet understood.  Al-
though various studies have attempted to explain the 
biological role of CAMs in AMs, it remains necessary 
to understand the interactions of these molecules with 
each other and with the various proteins involved in the 
proliferative, apoptotic and invasive pathways that are 
characteristic of AM tumorigenesis. Such an under-
standing might allow for the development of therapeutic 
applications that block the cell signaling pathways that 
are involved in the progression of AMs. 
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